Back to Search Start Over

Temporal Reduction in COVID-19-Associated Fatality Among Kidney Transplant Recipients: The Brazilian COVID-19 Registry Cohort Study.

Authors :
de Sandes-Freitas TV
Cristelli MP
Requião-Moura LR
Modelli de Andrade LG
Viana LA
Garcia VD
de Oliveira CMC
Esmeraldo RM
de Lima PR
Charpiot IMMF
Ferreira TCA
Franco RF
Costa KMAH
Simão DR
Ferreira GF
Santana VBBM
Almeida RAMB
Deboni LM
Saldanha ALDR
Noronha IL
de Oliveira LC
de Carvalho DBM
Oriá RB
Medina-Pestana JO
Tedesco-Silva Junior H
Source :
Transplant international : official journal of the European Society for Organ Transplantation [Transpl Int] 2022 Feb 01; Vol. 35, pp. 10205. Date of Electronic Publication: 2022 Feb 01 (Print Publication: 2022).
Publication Year :
2022

Abstract

Data from the general population suggest that fatality rates declined during the course of the pandemic. This analysis, using data extracted from the Brazilian Kidney Transplant COVID-19 Registry, seeks to determine fatality rates over time since the index case on March 3rd, 2020. Data from hospitalized patients with RT-PCR positive SARS-CoV-2 infection from March to August 2020 (35 sites, 878 patients) were compared using trend tests according to quartiles (Q1: <72 days; Q2: 72-104 days; Q3: 105-140 days; Q4: >140 days after the index case). The 28-day fatality decreased from 29.5% (Q1) to 18.8% (Q4) ( p <subscript> for-trend </subscript> = 0.004). In multivariable analysis, patients diagnosed in Q4 showed a 35% reduced risk of death. The trend of reducing fatality was associated with a lower number of comorbidities (20.7-10.6%, p <subscript> for-trend </subscript> = 0.002), younger age (55-53 years, p <subscript> for-trend </subscript> = 0.062), and better baseline renal function (43.6-47.7 ml/min/1.73 m <superscript>2</superscript> , p <subscript> for-trend </subscript> = 0.060), and were confirmed by multivariable analysis. The proportion of patients presenting dyspnea ( p <subscript> for-trend </subscript> = 0.001) and hypoxemia ( p <subscript> for-trend </subscript> < 0.001) at diagnosis, and requiring intensive care was also found reduced ( p <subscript> for-trend </subscript> = 0.038). Despite possible confounding variables and time-dependent sampling differences, we conclude that COVID-19-associated fatality decreased over time. Differences in demographics, clinical presentation, and treatment options might be involved.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2022 Sandes-Freitas, Cristelli, Requião-Moura, Modelli de Andrade, Viana, Garcia, de Oliveira, Esmeraldo, de Lima, Charpiot, Ferreira, Franco, Costa, Simão, Ferreira, Santana, Almeida, Deboni, Saldanha, Noronha, Oliveira, Carvalho, Oriá, Medina-Pestana and Tedesco-Silva Junior.)

Details

Language :
English
ISSN :
1432-2277
Volume :
35
Database :
MEDLINE
Journal :
Transplant international : official journal of the European Society for Organ Transplantation
Publication Type :
Academic Journal
Accession number :
35185380
Full Text :
https://doi.org/10.3389/ti.2022.10205